Stocks Health care CUPR

NASDAQ · Health care

Cuprina Holdings (Cayman) LTD (CUPR)

Cuprina Holdings (Cayman) LTD reported revenue of $38.8K in fiscal 2025, up 9.2% from a year earlier. It posted a net loss of $3.6M. In fiscal 2025 capital spending exceeded operating cash flow by $7.1M. At December 31, 2025 it held $2.4M in cash against $128.2K of debt. Its latest periodic report to the SEC is the annual report (foreign issuer, amended) (20-F/A) filed on July 1, 2026.

What Cuprina Holdings (Cayman) LTD does

Cuprina Holdings (Cayman) LTD is registered with the SEC under industry code SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Its shares trade on NASDAQ under the ticker CUPR.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Where CUPR ranks in Health care

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Cuprina Holdings (Cayman) LTD has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. September 18, 2026
   Foreign issuer update 6-K
2. September 18, 2026
   Foreign issuer update 6-K
3. September 16, 2026
   Securities offering prospectus 424B4
4. September 11, 2026
   IPO registration (foreign issuer) (amended) F-1/A
5. July 28, 2026
   Passive stake (5% or more) SCHEDULE 13G
6. July 7, 2026
   IPO registration (foreign issuer) F-1
7. July 1, 2026
   Annual report (foreign issuer, amended) 20-F/A · period to December 31, 2025Revenue rose 9.2% to $38.8K versus the prior year; diluted EPS -$17.75 versus -$6.38.
8. June 15, 2026
   Foreign issuer update 6-K
9. June 12, 2026
   Foreign issuer update 6-K
10. May 14, 2026
    Foreign issuer update 6-K

Recent insider filings (Forms 3, 4 and 144): 7, the latest on April 21, 2026. Insider transactions on SEC

Who owns CUPR

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

We have not read this company's Form 4 filings yet.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about CUPR

What does Cuprina Holdings (Cayman) LTD do?

Cuprina Holdings (Cayman) LTD is registered with the SEC under industry code SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Its shares trade on NASDAQ under the ticker CUPR.

Is Cuprina Holdings (Cayman) LTD profitable?

No. In fiscal 2025 it reported a net loss of $3.6M on revenue of $38.8K.

How much revenue does Cuprina Holdings (Cayman) LTD make?

In fiscal 2025 Cuprina Holdings (Cayman) LTD reported revenue of $38.8K. That is 9.2% more than a year earlier.

When did Cuprina Holdings (Cayman) LTD last report?

Its most recent periodic report is the annual report (foreign issuer, amended) (20-F/A) filed on July 1, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from September 18, 2026.

Similar companies

Compare CUPR with

Compare CUPR with any company

Follow CUPR

Get an email when Cuprina Holdings (Cayman) LTD files with the SEC: results, executive changes, material agreements and annual reports.

Follow CUPR: get an email when it files

Where the numbers come from

Financial figures are the values Cuprina Holdings (Cayman) LTD tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.